Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prochymal in Moderate to Severe COPD
NCT00683722Phase 2Completed
- Sponsor
- Mesoblast Ltd
- Start
- Mar 2008
- Primary completion
- Mar 2009
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of remestemcel-L-rknd in chronic obstructive pulmonary disease (COPD), sponsored by Mesoblast Ltd. Started Mar 2008; status: completed.
02
Drugs
remestemcel-L-rknd
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00683722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00683722.